1 BTC
=
- USD
AlloVir, Inc. Common Stock
As of May 30, 2026 at 24:05 UTC
Chart
About AlloVir, Inc. Common Stock
AlloVir Inc is a biopharmaceutical company. The company focuses on developing allogeneic T-cell therapies to combat viral diseases. Their proprietary virus-specific T cell VST therapy platform enables the creation of off-the-shelf VSTs, therapy platform allows AlloVir to generate off-the-shelf VSTs designed to restore immunity in patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. This included: (1) posoleucel (ALVR105), an investigational off-the-shelf multi-virus-specific T cell therapy. (2) ALVR106, an allogeneic, off-the-shelf VST therapy candidate developed to target devastating diseases caused by four respiratory viruses. (3) ALVR107, an allogeneic, off-the-shelf VST therapy candidate designed to target hepatitis B (HBV).
Market Statistics
Trading Metrics
How to Buy ALVR
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy ALVR
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesKalaris Therapeutics and AlloVir announced that AlloVir stockholders have approved the proposed merger between the two companies. The combined company is expected to be renamed Kalaris Therapeutics and trade on Nasdaq under the ticker 'KLRS'.
Halper Sadeh LLC is investigating several companies for potential violations of securities laws and breaches of fiduciary duties to shareholders, including The Interpublic Group of Companies, Stronghold Digital Mining, William Penn Bancorporation, and AlloVir.
